|
1.
|
Folkman J and Shing Y: Angiogenesis. J
Biol Chem. 267:10931–10934. 1992.
|
|
2.
|
Siddiqui FA, Desai H, Siddiqui TF and
Francis JL: Hemoglobin induces the expression and secretion of
vascular endothelial growth factor from human malignant cells.
Hematol J. 3:264–270. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Ferrara N and Kerbel RS: Angiogenesis as
therapeutic target. Nature. 438:967–974. 2005. View Article : Google Scholar
|
|
5.
|
Isner JM and Asahara T: Angiogenesis and
vasculogenesis as therapeutics strategies for postnatal
neovascularization. J Clin Invest. 103:1231–1236. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Folkman J: Tumor angiogenesis: therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Balkwill F and Mantovani A: Inflammation
and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Albini A, Tosetti F, Benelli R and Noonan
DM: Tumor inflammatory angiogenesis and its chemoprevention. Cancer
Res. 65:10637–10641. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Aggarwal BB, Shishodia S, Sandur SK,
Pandey MK and Sethi G: Inflammation and cancer: how hot is the
link? Biochem Pharmacol. 72:1605–1621. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Sgambato A and Cittadini A: Inflammation
and cancer: a multifaceted link. Eur Rev Med Pharmacol Sci.
14:263–268. 2010.
|
|
11.
|
Raman D, Sobolik-Delmaire T and Richmond
A: Chemokines in health and disease. Exper Cell Res. 317:575–589.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Rock GA and Dalgleish A: Infection,
immunoregulation, and cancer. Immunol Rev. 240:141–159. 2011.
View Article : Google Scholar
|
|
13.
|
Grivennikov SI and Karin M: Inflammation
and oncogenesis: a vicious connection. Curr Opin Genet Dev.
20:65–71. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Yoshimura A: Signal transduction of
inflammatory cytokines and tumor development. Cancer Sci.
97:439–447. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Karin M and Greteo FR: NF-kappaB: linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Naldini A and Carraro F: Role of
inflammatory mediators in angiogenesis. Curr Drug Targets Inflam
Allergy. 4:3–8. 2005. View Article : Google Scholar
|
|
17.
|
da Rocha AB, Lopes RM and Schwartsmann G:
Natural products in anticancer therapy. Curr Opin Pharmacol.
1:364–369. 2001.PubMed/NCBI
|
|
18.
|
Granci V, Dupertuis YM and Pichard C:
Agiogenesis as a potential target of pharmaconutients in cancer
therapy. Curr Opin Clin Nutr Metab Care. 13:417–422. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Craig SA: Betaine in human nutrition. Am J
Clin Nutr. 80:539–549. 2004.PubMed/NCBI
|
|
20.
|
Schrama JW, Heetkamp MJ, Simmins PH and
Gerrits WJ: Dietary betaine supplementation affects energy
metabolism of pigs. J Anim Sci. 81:1202–1209. 2003.PubMed/NCBI
|
|
21.
|
Holm PI, Ueland PM, Vollset SE, et al:
Betaine and folate status as cooperative determinants of plasma
homocysteine in humans. Arterioscler Thromb Vasc Biol. 25:379–385.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kim SK, Choi KH and Kim YC: Effect of
acute betaine administration on hepatic metabolism of S-amino acids
in rats and mice. Biochem Pharmacol. 65:1565–1574. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Garcia-Perez A and Burg MB: Renal
medullary organic osmolytes. Physiol Rev. 71:1081–1115. 1991.
|
|
24.
|
Sakamoto A and Murata N: Genetic
engineering of glycine betaine synthesis in plants: current status
and implications for enhancement of stress tolerance. J Exp Bot.
51:81–88. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Steenge GR, Verhoef P and Katan MB:
Betaine supplementation lowers plasma homocysteine in healthy men
and women. J Nutr. 133:1291–1295. 2003.PubMed/NCBI
|
|
26.
|
Go EK, Jung KJ, Kim JY, Yu BP and Chung
HY: Betaine suppresses proinflammatory signaling during aging: the
involvement of nuclear factor-kappaB via nuclear factor-inducing
kinase/IkappaB kinase and mitogen-activated protein kinases. J
Gerontol A Biol Sci Med Sci. 60:1252–1264. 2005. View Article : Google Scholar
|
|
27.
|
Dobrzanski P, Hunter K, Jones-Bolin S, et
al: Antiangiogenic and antitumor efficacy of EphA2 receptor
antagonist. Cancer Res. 64:910–919. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Lin YG, Kunnumarkkara AB, Nair A, et al:
Curcumin inhibits growth and angiogenesis in ovarian carcinoma by
targeting the nuclear factor-kappaB pathway. Clin Cancer Res.
13:3423–3430. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Szekanecz Z and Koch AE: Endothelial cells
in inflammation and angiogenesis. Curr Drug Targets Inflamm
Allergy. 4:319–323. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Ono M: Molecular links between tumor
angiogenesis and inflammation: inflammatory stimuli of macrophages
and cancer cells as targets for therapeutic strategy. Cancer Sci.
99:1501–1506. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Jones KM, Wang H, Peskar BM, et al:
Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs:
insight into mechanism and implications for cancer growth ulcer
healing. Nat Med. 5:1418–1423. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Cragg G and Suffness M: Metabolism of
plant-derived anticancer agents. Pharmacol Ther. 37:425–461. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Wani MC, Taylor HL, Wall ME, Coggon P and
McPhail AT: Plant antitumor agents. VI. The isolation and structure
of taxol, a novel antileukemic and antitumor agent from Taxus
brevifolia. J Am Chem Soc. 93:2325–2327. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Nagy JA, Dvorak AM and Dvorak HF:
EGF-A(164/165) and PIGF: roles in angiogenesis and arteriogenesis.
Trends Cardiovasc Med. 13:169–175. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Tsuda H, Ohshima Y, Nomoto H, et al:
Cancer prevention by natural compounds. Drug Metab Pharmacokinet.
19:245–263. 2004. View Article : Google Scholar
|
|
36.
|
Parikh AA and Ellis LM: The vascular
endothelial growth factor family and its receptors. Hematol Oncol
Clin North Am. 18:951–971. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Munoz-Chapuli R, Quesada AR and Angel
Medina M: Angiogenesis and signal transduction in endothelial
cells. Cell Mol Life Sci. 61:2224–2243. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Blavier L, Lazaryev A, Dorey F,
Shackleford GM and DeClerck TA: Matrix metalloproteinases play an
active role in Wnt1-induced mammary tumorigenesis. Cancer Res.
66:2691–2699. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Bisacchi D, Benelli R, Venzetto C, Ferrari
N, Tosetti F and Albini A: Anti-angiognesis and angioprevention:
mechanisms, problems and perspectives. Cancer Detect Prev.
27:229–238. 2003. View Article : Google Scholar : PubMed/NCBI
|
